Baqsimi 3 mg nasal powder in single-dose container

Licence status
Authorised: 16/12/2019
Active substances
GLUCAGON
Dosage Form
Nasal powder in single-dose container
Licence number
EU/1/19/1406/001-002
Licence holder
Amphastar France Pharmaceuticals, S.A.S.

Product documents

Licence information

ATC code
H04AA Glycogenolytic hormones, H04AA01 glucagon
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/12/2019